CSRxP Applauds Advancement Of Bipartisan CREATES Act
Apr 30, 2019
Praises Lawmakers For Commitment To Delivering Relief For Patients Washington,… Read More
© 2025 CSRXP- All Rights Reserved
Updates
CSRxP Applauds Continued Drug Price Activity & Momentum On Capitol Hill
Apr 29, 2019
Encourages House Judiciary Committee To Advance Bipartisan CREATES Act… Read More
Big Pharma Earnings Watch
Apr 27, 2019
Big Pharma Flying High: Sanofi & AstraZeneca Beat First Quarter Profit… Read More
Big Pharma Earnings Watch: Bristol-Myers Squibb
Apr 26, 2019
Trend Emerges: Bristol-Myers Squibb Joins Big Pharma Colleagues Beating First… Read More
Big Pharma Earnings Watch: AbbVie
Apr 26, 2019
AbbVie Beats Forecast But Dips In Revenue In Demonstration That Competition… Read More
Big Pharma Earnings Watch: Novartis
Apr 24, 2019
Novartis Beats Profit Forecasts After Jacking Up Prices On Dozens Of Drugs Big… Read More
Big Pharma’s Record Spending On Lobbying Won’t Slow Bipartisan Momentum On Drug Prices
Apr 23, 2019
Filings Show Drug Makers Spent Nearly $10 Million on Lobbying in Q1 2019 –… Read More
Second Opinion: Boosted Ad Budgets Undercut Big Pharma’s R&D Rhetoric
Apr 17, 2019
New Report Finds Drug Makers Spent Whopping $6.46 Billion On Advertising In… Read More
CSRxP Applauds Introduction Of Cassidy-Durbin “REMEDY Act”
Apr 11, 2019
Bipartisan Bill Would Take Meaningful Steps To Crack Down On Big Pharma’s… Read More
CSRxP: New Study Highlights How Big Pharma’s Price-Gouging Burdens Taxpayers, Harms Patients
Apr 11, 2019
Bloomberg Analysis Finds Medicare Spending On 22 Drugs Jumped More Than 500… Read More
THEY SAID IT! Lawmakers Vow Action To Lower Insulin Prices & Criticize Pharma For Price-Gouging, Blame Game
Apr 11, 2019
Today, the U.S. House Committee on Energy and Commerce Subcommittee on… Read More
Big Pharma Needs To Be Held Accountable For Lead Role In Rising Insulin Prices
Apr 10, 2019
On Wednesday, executives from the three biggest makers of insulin, Novo… Read More